U
Protect Pharmaceutical Corporation
PRTT
$1.30
-$0.046-3.42%
D
Sell
8/19/2019Downgrade
Protect Pharmaceutical Corporation (PRTT) was downgraded to D from D+ on 8/19/2019 due to a significant decline in the solvency index, total return index and volatility index.
Protect Pharmaceutical Corporation (PRTT) was downgraded to D from D+ on 8/19/2019 due to a significant decline in the solvency index, total return index and volatility index.
D
Sell
2/27/2019Upgraded
Protect Pharmaceutical Corporation (PRTT) was upgraded to D+ from D on 2/27/2019 due to a significant increase in the efficiency index, solvency index and volatility index.
Protect Pharmaceutical Corporation (PRTT) was upgraded to D+ from D on 2/27/2019 due to a significant increase in the efficiency index, solvency index and volatility index.
D
Sell
8/8/2017Downgrade
Protect Pharmaceutical Corporation (PRTT) was downgraded to D from D+ on 8/8/2017 due to a decline in the volatility index and valuation index.
Protect Pharmaceutical Corporation (PRTT) was downgraded to D from D+ on 8/8/2017 due to a decline in the volatility index and valuation index.
D
Sell
7/10/2017Upgraded
Protect Pharmaceutical Corporation (PRTT) was upgraded to D+ from D on 7/10/2017 due to a large increase in the total return index, growth index and volatility index. Operating cash flow increased 100% from -$14.2 to $0, EBIT increased 24.51% from -$20.4 to -$15.4, and earnings per share increased from -$0.0184 to -$0.0139.
Protect Pharmaceutical Corporation (PRTT) was upgraded to D+ from D on 7/10/2017 due to a large increase in the total return index, growth index and volatility index. Operating cash flow increased 100% from -$14.2 to $0, EBIT increased 24.51% from -$20.4 to -$15.4, and earnings per share increased from -$0.0184 to -$0.0139.
D
Sell
3/31/2017Downgrade
Protect Pharmaceutical Corporation (PRTT) was downgraded to D from D+ on 3/31/2017 due to a significant decline in the efficiency index, growth index and total return index. Total capital declined 2,500% from -$800 to -$20.8, operating cash flow declined 265.12% from $8.6 to -$14.2, and earnings per share declined from -$0.0064 to -$0.0208.
Protect Pharmaceutical Corporation (PRTT) was downgraded to D from D+ on 3/31/2017 due to a significant decline in the efficiency index, growth index and total return index. Total capital declined 2,500% from -$800 to -$20.8, operating cash flow declined 265.12% from $8.6 to -$14.2, and earnings per share declined from -$0.0064 to -$0.0208.
D
Sell
2/22/2017Downgrade
Protect Pharmaceutical Corporation (PRTT) was downgraded to D+ from C- on 2/22/2017 due to a decline in the volatility index.
Protect Pharmaceutical Corporation (PRTT) was downgraded to D+ from C- on 2/22/2017 due to a decline in the volatility index.
C
Hold
2/7/2017Upgraded
Protect Pharmaceutical Corporation (PRTT) was upgraded to C- from D+ on 2/7/2017 due to an increase in the total return index.
Protect Pharmaceutical Corporation (PRTT) was upgraded to C- from D+ on 2/7/2017 due to an increase in the total return index.
D
Sell
1/23/2017Downgrade
Protect Pharmaceutical Corporation (PRTT) was downgraded to D+ from C- on 1/23/2017 due to a decline in the volatility index and valuation index.
Protect Pharmaceutical Corporation (PRTT) was downgraded to D+ from C- on 1/23/2017 due to a decline in the volatility index and valuation index.
C
Hold
11/25/2016Upgraded
Protect Pharmaceutical Corporation (PRTT) was upgraded to C- from D+ on 11/25/2016 due to an increase in the growth index and total return index.
Protect Pharmaceutical Corporation (PRTT) was upgraded to C- from D+ on 11/25/2016 due to an increase in the growth index and total return index.
D
Sell
11/23/2016Upgraded
Protect Pharmaceutical Corporation (PRTT) was upgraded to D+ from D on 11/23/2016 due to a significant increase in the efficiency index, total return index and growth index. Operating cash flow increased 232.31% from -$6.5 to $8.6, total capital increased 98.89% from -$71.9 to -$800, and net income increased 31.43% from -$10.5 to -$7.2.
Protect Pharmaceutical Corporation (PRTT) was upgraded to D+ from D on 11/23/2016 due to a significant increase in the efficiency index, total return index and growth index. Operating cash flow increased 232.31% from -$6.5 to $8.6, total capital increased 98.89% from -$71.9 to -$800, and net income increased 31.43% from -$10.5 to -$7.2.
D
Sell
10/4/2016Upgraded
Protect Pharmaceutical Corporation (PRTT) was upgraded to D from D- on 10/4/2016 due to an increase in the volatility index and total return index.
Protect Pharmaceutical Corporation (PRTT) was upgraded to D from D- on 10/4/2016 due to an increase in the volatility index and total return index.
D
Sell
4/15/2016Downgrade
Protect Pharmaceutical Corporation (PRTT) was downgraded to D- from D on 4/15/2016 due to a significant decline in the valuation index, efficiency index and growth index. Total capital declined 5.24% from -$95.4 to -$100.4.
Protect Pharmaceutical Corporation (PRTT) was downgraded to D- from D on 4/15/2016 due to a significant decline in the valuation index, efficiency index and growth index. Total capital declined 5.24% from -$95.4 to -$100.4.
D
Sell
3/24/2016Downgrade
Protect Pharmaceutical Corporation (PRTT) was downgraded to D from D+ on 3/24/2016 due to a decline in the total return index and volatility index.
Protect Pharmaceutical Corporation (PRTT) was downgraded to D from D+ on 3/24/2016 due to a decline in the total return index and volatility index.
D
Sell
3/11/2016Downgrade
Protect Pharmaceutical Corporation (PRTT) was downgraded to D+ from C on 3/11/2016 due to a substantial decline in the volatility index and total return index.
Protect Pharmaceutical Corporation (PRTT) was downgraded to D+ from C on 3/11/2016 due to a substantial decline in the volatility index and total return index.
C
Hold
11/18/2015Upgraded
Protect Pharmaceutical Corporation (PRTT) was upgraded to C from D on 11/18/2015 due to a significant increase in the efficiency index and volatility index. Net income increased 8,003.95% from -$7.6 to -$615.9.
Protect Pharmaceutical Corporation (PRTT) was upgraded to C from D on 11/18/2015 due to a significant increase in the efficiency index and volatility index. Net income increased 8,003.95% from -$7.6 to -$615.9.
D
Sell
10/22/2015Downgrade
Protect Pharmaceutical Corporation (PRTT) was downgraded to D from D+ on 10/22/2015 due to a substantial decline in the volatility index.
Protect Pharmaceutical Corporation (PRTT) was downgraded to D from D+ on 10/22/2015 due to a substantial decline in the volatility index.
D
Sell
10/7/2015Upgraded
Protect Pharmaceutical Corporation (PRTT) was upgraded to D+ from D on 10/7/2015 due to a substantial increase in the volatility index and efficiency index. Net income increased 35.71% from -$5.6 to -$7.6, and total capital increased 4.72% from -$125.1 to -$131.
Protect Pharmaceutical Corporation (PRTT) was upgraded to D+ from D on 10/7/2015 due to a substantial increase in the volatility index and efficiency index. Net income increased 35.71% from -$5.6 to -$7.6, and total capital increased 4.72% from -$125.1 to -$131.
D
Sell
4/16/2015Downgrade
Protect Pharmaceutical Corporation (PRTT) was downgraded to D from C on 4/16/2015 due to a significant decline in the efficiency index, volatility index and total return index. Net income declined 6,555.41% from -$7.4 to $477.7, and total capital declined 78.54% from -$563.8 to -$121.
Protect Pharmaceutical Corporation (PRTT) was downgraded to D from C on 4/16/2015 due to a significant decline in the efficiency index, volatility index and total return index. Net income declined 6,555.41% from -$7.4 to $477.7, and total capital declined 78.54% from -$563.8 to -$121.
C
Hold
12/4/2014Downgrade
Protect Pharmaceutical Corporation (PRTTD) was downgraded to C from C+ on 12/4/2014 due to a large decline in the total return index and volatility index.
Protect Pharmaceutical Corporation (PRTTD) was downgraded to C from C+ on 12/4/2014 due to a large decline in the total return index and volatility index.
C
Hold
11/19/2014Upgraded
Protect Pharmaceutical Corporation (PRTTD) was upgraded to C+ from C on 11/19/2014 due to a significant increase in the total return index, growth index and volatility index.
Protect Pharmaceutical Corporation (PRTTD) was upgraded to C+ from C on 11/19/2014 due to a significant increase in the total return index, growth index and volatility index.
C
Hold
9/26/2014Upgraded
Protect Pharmaceutical Corporation (PRTT) was upgraded to C from C- on 9/26/2014 due to a major increase in the volatility index and efficiency index.
Protect Pharmaceutical Corporation (PRTT) was upgraded to C from C- on 9/26/2014 due to a major increase in the volatility index and efficiency index.
C
Hold
8/21/2014Downgrade
Protect Pharmaceutical Corporation (PRTT) was downgraded to C- from C on 8/21/2014 due to a significant decline in the volatility index and growth index.
Protect Pharmaceutical Corporation (PRTT) was downgraded to C- from C on 8/21/2014 due to a significant decline in the volatility index and growth index.
OTC PK
04/02/2025 10:11AM Eastern
Quotes delayed
